Ergoteles’s Aerie Pharmaceuticals AERI Stock Holding History

Ergoteles’s Portfolio AERI Stock Details AERI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-428,184	Closed	-$6.48M	–	2147
2022 Q3	$6.48M	Buy	+428,184	New	+$4.98M	0.23%	90
2022 Q2	–	Sell	-48,400	Closed	-$440K	–	2130
2022 Q1	$440K	Sell	48,400 -8,000	-14%	-$61.7K	0.02%	708
2021 Q4	$396K	Buy	+56,400	New	+$590K	0.02%	735

Ergoteles's AERI Position: Q4 2022 in Review

Ergoteles sold out of Aerie Pharmaceuticals (AERI) in Q4 2022, closing a stake of 428,184 shares — an estimated $6.48M sold.

Ergoteles first reported a position in AERI in Q4 2021 and held it in 3 quarters. The position peaked at $6.48M in Q3 2022. 0 funds tracked by Wall St. Rank hold AERI as of Q4 2022.

Ergoteles reported no remaining Aerie Pharmaceuticals position as of Q4 2022 after selling out during the quarter.
Ergoteles sold 428,184 Aerie Pharmaceuticals shares in Q4 2022, an estimated $6.48M.
Ergoteles first reported a position in Aerie Pharmaceuticals in Q4 2021 and held it in 3 quarters.
Ergoteles's Aerie Pharmaceuticals position peaked at $6.48M in Q3 2022.
0 funds tracked by Wall St. Rank held Aerie Pharmaceuticals as of Q4 2022.

Based on Ergoteles's 13F filing for Q4 2022, filed 14 Feb 2023.